(2S,3R,4S,5R)-2-(3-(naphthalen-2-yl)-1H-1,2,4-triazol-5-yl)tetrahydro-2H-pyran-3,4,5-triol

ID: ALA4089805

PubChem CID: 89526202

Max Phase: Preclinical

Molecular Formula: C17H17N3O4

Molecular Weight: 327.34

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O[C@@H]1[C@@H](O)[C@H](c2nc(-c3ccc4ccccc4c3)n[nH]2)OC[C@H]1O

Standard InChI:  InChI=1S/C17H17N3O4/c21-12-8-24-15(14(23)13(12)22)17-18-16(19-20-17)11-6-5-9-3-1-2-4-10(9)7-11/h1-7,12-15,21-23H,8H2,(H,18,19,20)/t12-,13+,14-,15-/m1/s1

Standard InChI Key:  JJSUZQIOLALQGD-LXTVHRRPSA-N

Molfile:  

     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
    4.4745  -11.6443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4745  -13.2836    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0541  -14.1034    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6378  -13.2837    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0541  -11.6443    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7684  -12.0520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7684  -12.8717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0541  -13.2837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480  -12.8718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480  -12.0521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2194  -11.9742    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7650  -11.3682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3572  -10.6620    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5597  -10.8317    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5777  -11.4535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9089  -12.2013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7208  -12.2869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0544  -10.7939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8654  -10.8759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1983  -11.6262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0127  -11.7118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4951  -11.0480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1573  -10.2966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3439  -10.2146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 10  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  6  1  1  1
  7  2  1  6
  8  3  1  1
  9  4  1  6
  1 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14  1  1  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 20  2  0
 19 18  2  0
 18 15  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  END

Alternative Forms

Associated Targets(non-human)

PYGM Glycogen phosphorylase, muscle form (1331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 327.34Molecular Weight (Monoisotopic): 327.1219AlogP: 0.78#Rotatable Bonds: 2
Polar Surface Area: 111.49Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 9.48CX Basic pKa: 0.50CX LogP: 1.08CX LogD: 1.08
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.55Np Likeness Score: 0.04

References

1. Bokor É, Kyriakis E, Solovou TGA, Koppány C, Kantsadi AL, Szabó KE, Szakács A, Stravodimos GA, Docsa T, Skamnaki VT, Zographos SE, Gergely P, Leonidas DD, Somsák L..  (2017)  Nanomolar Inhibitors of Glycogen Phosphorylase Based on β-d-Glucosaminyl Heterocycles: A Combined Synthetic, Enzyme Kinetic, and Protein Crystallography Study.,  60  (22): [PMID:28925695] [10.1021/acs.jmedchem.7b01056]

Source